Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.
Ratings are attributed to the research firm, not to individual analysts. Latest event 15h ago.
| Ticker | Firm | Action | Rating | Target | Date |
|---|---|---|---|---|---|
| VERAVera Therapeutics, Inc. | HC Wainwright & Co. | Maintained | Buy | $125 $90 | Aug 12 |
| IONSIonis Pharmaceuticals, Inc. | HC Wainwright & Co. | Maintained | Buy | $115 $100 | 2d ago |
| ASSTStrive, Inc. |
Showing the 12 most recent target moves.
| Maintained |
| Buy |
| $37 $36 |
| Aug 11 |
| ASNDAscendis Pharma A/S | HC Wainwright & Co. | Maintained | Buy | $345 $344 | Aug 31 |
| BLTEBelite Bio, Inc | HC Wainwright & Co. | Maintained | Buy | $200 $214 | Aug 12 |
| BLTEBelite Bio, Inc | HC Wainwright & Co. | Maintained | Buy | $214 $245 | 1d ago |
| ROIVRoivant Sciences Ltd. | HC Wainwright & Co. | Maintained | Buy | $41 $47 | 1d ago |
| COAGHemab Therapeutics Holdings, Inc. | HC Wainwright & Co. | Maintained | Buy | $52 $60 | Aug 11 |
| GENBGenerate Biomedicines, Inc. | HC Wainwright & Co. | Maintained | Buy | $25 $30 | Aug 28 |
| CLMTCalumet, Inc. | HC Wainwright & Co. | Maintained | Buy | $60 $75 | Sep 2 |
| ARGXargenx SE | HC Wainwright & Co. | Maintained | Buy | $940 $1,202 | Aug 18 |
| AMLXAmylyx Pharmaceuticals, Inc. | HC Wainwright & Co. | Maintained | Buy | $34 $55 | Aug 18 |